TDMQ20 as A Drug Candidate for Wilson's Disease: Comparison with D-Penicillamine, Trientine, and Tetrathiomolybdate In Vitro and In Mice.

Pharmaceutics · 2025 · PMC12473319 · PMID 41012571

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The treatment with TDMQ20 at 12.5 mg/kg/d and 25 mg/kg/d resulted in an increasing trend, but the results were not statistically significant.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.